Pharma 2 News: Pharma 2 Latest News, Pharma 2 Today news, Pharma 2 Breaking News

Inside a modern, sterile pharmaceutical manufacturing plant showing technicians managing an automated medicine packaging and generic drug formulation line.

IPCA Laboratories: Emkay Global sees 21% upside; projects 12–13% FY27 sales growth

Emkay Global sees 21% upside for IPCA Labs, fueled by strong earnings and sales growth. Discover why analysts rate it…

June 3, 2026 11:40 IST

A professional dual-monitor setup displaying technical analysis candlestick charts, MACD indicators, and moving averages for the Nifty Pharma and Metal indices on a financial trading desk.

Monday Watchlist: Nifty volatility persists as pharma and metal indices flash short-term reversal signals

Monday watchlist today, June 01: Nifty volatility continues as pharma and metal indices signal short-term reversals; review your trading strategy…

June 1, 2026 05:30 IST

IT, pharma, textiles may gain while auto and jewellery face pressure from currency shock

Rupee near 96: The currency shock creating winners and losers across 5 key sectors

Analysts say a depreciating rupee may help export-oriented sectors like IT, pharmaceuticals and textiles, while automobiles and jewellery could face…

Updated: May 26, 2026 13:50 IST

Stock market electronic display board screen showing green bullish trend tickers for major private banks alongside a dipping consumer goods sector chart.

Market Watchlist: FII long-buildup sets stage for Nifty breakout; Private Banks lead, FMCG lags

Monday watchlist, May 24: FIIs spark fresh optimism with Friday longs; Private Banks set for a rally—track the momentum and…

May 25, 2026 05:30 IST

Sun Pharmaceuticals posted 26% YoY profit growth in the March quarter.

Sun Pharma Q4 profit rises 26% to Rs 2,714 crore, revenue grows 13%, dividend announced

Sun Pharma posted strong Q4 profit and revenue growth as its India business gained market share and innovative medicines business…

May 22, 2026 16:05 IST

3 Nifty 500 Stocks to Watch that are Nearing their 52-Week Highs

Here is a list of Nifty 500 stocks that hit new 52-week highs today.

May 22, 2026 11:55 IST

Bernstein pharma report on Indian healthcare growth with Zydus Lupin and Sun Pharma

Bernstein initiates coverage on 6 Indian Pharma Stocks: With 3 ‘Outperforms’ and 2 ‘Underperforms’

Indian pharma may be entering a new era. Bernstein says the next winners may not come from vanilla generics but…

Updated: May 22, 2026 10:50 IST

An infographic comparing Nomura’s target prices for Dr. Reddy’s, Cipla, and Crompton Greaves, highlighting growth drivers like GLP-1 drug traction and ECD market expansion.

Cipla, Dr Reddy’s Lab, Crompton Greaves: Nomura’s top picks with 17% to 26% upside potential

Nomura sees up to 26% upside in Cipla, Dr Reddy’s Lab, and Crompton Greaves—discover why these stocks are top picks…

Updated: May 14, 2026 15:29 IST

Top 5 Pharma Mutual Funds in India 2026

Investors are increasingly tracking pharma mutual funds for sector-focused opportunities. We reviewed five leading pharma mutual funds based on returns,…

May 14, 2026 13:28 IST

Cipla jumps 8% despite 55% profit drop: Why are brokerages positive on the drugmaker

Cipla surges 8% despite 55% profit drop as brokerages turn bullish—explore if this rally signals a buying opportunity!

May 14, 2026 13:05 IST

Cipla Q4 profit drops 55% to Rs 555 crore; announces Rs 13 dividend

Cipla Q4 profit plunges 55% to Rs 555 crore; company announces Rs 13 dividend. Learn more about Cipla’s financial results!

Updated: May 13, 2026 16:19 IST

Govt to rope in a firm to reduce the logistics cost for pharma and MedTech companies as West Asia conflict drives price surge

Government to hire consultant to study pharma, MedTech logistics, aiming to cut costs, fix cold-chain gaps and ease regulatory bottlenecks…

April 21, 2026 20:07 IST

Aurobindo Pharma Buyback: Rs 800 crore plan at 6% premium; Check key dates and price details

Aurobindo Pharma announces Rs 800 crore buyback at 6% premium, opening April 23. Check eligibility and key dates!

April 21, 2026 17:49 IST

Lupin has settled multiple lawsuits in the United States.

Lupin to pay $30 million to settle multiple lawsuits in US; denies all allegations

Lupin settles US antitrust lawsuits for $30 million with Humana, denies wrongdoing, and aims to avoid prolonged legal costs and…

April 17, 2026 14:15 IST

HSBC India Underweight rating April 2026 stock market impact

Cipla to Sun Pharma: Nomura rates these 6 pharma stocks, riding the GLP-1 wave, ‘Buy’

The Indian Pharmaceutical Market (IPM) grew 10.1% year-on-year in March 2026, according to the report. Pricing contributed 5.5% to growth,…

Updated: April 15, 2026 15:21 IST

Bombay High Court Urges Second Round of Mediation to End Multi-Year Asset Battle

Bombay HC ruling boosts pricing freedom for drugmakers, pharma firms raise concerns

Bombay High Court rules that drug variants not listed in NLEM are exempt from price caps under DPCO 2013, offering…

Updated: April 15, 2026 10:28 IST

Government Allocates Critical Petrochemicals to Avert Drug Shortages Amid West Asia Crisis

Domestic refiners step up as pharma feedstock imports hit by conflict

To counter supply chain disruptions from the West Asia conflict, the Indian government has initiated pro-rata allocation of key petrochemicals…

April 10, 2026 00:05 IST

Forget the market crash: Why these 2 specialty chemical stocks are hitting fresh highs

Despite weak market conditions, two speciality chemical stocks are delivering strong returns. Here’s why.

April 8, 2026 05:27 IST

pharma

Related News

Trending Topics